CBDBY Statistics
Total Valuation
CBDBY has a market cap or net worth of 343.87 million. The enterprise value is 1.65 billion.
| Market Cap | 343.87M |
| Enterprise Value | 1.65B |
Important Dates
The next estimated earnings date is Tuesday, November 4, 2025.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +45.83% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 33.15% |
| Owned by Institutions (%) | 46.19% |
| Float | 168.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.10 |
| PB Ratio | 0.73 |
| P/TBV Ratio | 1.64 |
| P/FCF Ratio | 2.67 |
| P/OCF Ratio | 1.40 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.45, with an EV/FCF ratio of 12.86.
| EV / Earnings | -5.01 |
| EV / Sales | 0.46 |
| EV / EBITDA | 7.45 |
| EV / EBIT | 27.38 |
| EV / FCF | 12.86 |
Financial Position
The company has a current ratio of 0.95, with a Debt / Equity ratio of 3.42.
| Current Ratio | 0.95 |
| Quick Ratio | 0.51 |
| Debt / Equity | 3.42 |
| Debt / EBITDA | 7.85 |
| Debt / FCF | 12.52 |
| Interest Coverage | 0.24 |
Financial Efficiency
Return on equity (ROE) is -36.37% and return on invested capital (ROIC) is 1.29%.
| Return on Equity (ROE) | -36.37% |
| Return on Assets (ROA) | 0.83% |
| Return on Invested Capital (ROIC) | 1.29% |
| Return on Capital Employed (ROCE) | 1.98% |
| Revenue Per Employee | 31,964 |
| Profits Per Employee | -3,003 |
| Employee Count | 110,000 |
| Asset Turnover | 1.00 |
| Inventory Turnover | 7.08 |
Taxes
| Income Tax | -33.59M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +23.78% in the last 52 weeks. The beta is 1.43, so CBDBY's price volatility has been higher than the market average.
| Beta (5Y) | 1.43 |
| 52-Week Price Change | +23.78% |
| 50-Day Moving Average | 0.67 |
| 200-Day Moving Average | 0.55 |
| Relative Strength Index (RSI) | 46.43 |
| Average Volume (20 Days) | 4,485 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CBDBY had revenue of 3.52 billion and -330.35 million in losses. Loss per share was -0.67.
| Revenue | 3.52B |
| Gross Profit | 964.80M |
| Operating Income | 46.80M |
| Pretax Income | -263.91M |
| Net Income | -330.35M |
| EBITDA | 120.58M |
| EBIT | 46.80M |
| Loss Per Share | -0.67 |
Balance Sheet
The company has 327.60 million in cash and 1.61 billion in debt, giving a net cash position of -1.28 billion.
| Cash & Cash Equivalents | 327.60M |
| Total Debt | 1.61B |
| Net Cash | -1.28B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 470.56M |
| Book Value Per Share | 0.96 |
| Working Capital | -54.51M |
Cash Flow
In the last 12 months, operating cash flow was 246.11 million and capital expenditures -117.46 million, giving a free cash flow of 128.65 million.
| Operating Cash Flow | 246.11M |
| Capital Expenditures | -117.46M |
| Free Cash Flow | 128.65M |
| FCF Per Share | n/a |
Margins
Gross margin is 27.44%, with operating and profit margins of 1.33% and -9.40%.
| Gross Margin | 27.44% |
| Operating Margin | 1.33% |
| Pretax Margin | -7.51% |
| Profit Margin | -9.40% |
| EBITDA Margin | 3.43% |
| EBIT Margin | 1.33% |
| FCF Margin | 3.66% |
Dividends & Yields
CBDBY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -45.83% |
| Shareholder Yield | -45.83% |
| Earnings Yield | -96.07% |
| FCF Yield | 37.41% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 18, 2010. It was a forward split with a ratio of 2.
| Last Split Date | Oct 18, 2010 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
CBDBY has an Altman Z-Score of 1.13 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.13 |
| Piotroski F-Score | 5 |